In 200 patients with axial spondyloarthritis on stable drug treatment, 12 weeks of a smartphone exercise and education app vs standard care improved BASDAI (difference −1.51), function and quality of life in the 186 completers; ASAS20 response was 51% vs 9%.
RCTn = 200
Strunz et al. An app-based nonpharmacological intervention improves patient-reported disease activity, functionality, and quality of life in patients with axial spondyloarthritis: a randomised controlled trial